YUHSpace

BROWSE

Export
1 4

Cited 3 times in

Cited 0 times in

Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers

DC Field Value Language
dc.contributor.authorLee, Sung Jong-
dc.contributor.authorYoo, Ji Geun-
dc.contributor.authorKim, Jin Hwi-
dc.contributor.authorPark, Jeong-Yeol-
dc.contributor.authorLee, Jung-Yun-
dc.contributor.authorLee, Yoo-Young-
dc.contributor.authorSuh, Dong Hoon-
dc.date.accessioned2025-11-18T01:56:01Z-
dc.date.available2025-11-18T01:56:01Z-
dc.date.created2025-07-16-
dc.date.issued2025-01-
dc.identifier.issn2005-0380-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/208930-
dc.description.abstractThis review summarized the results of clinical trials in 2024 that were believed to have a significant impact on clinical practice in the field of gynecologic oncology. The SHAPE trial, INTERLACE and KEYNOTE-A18 trials, and BEATcc and COMPASSION-16 trials were included in early-stage, locally advanced, and recurrent/metastatic cervical cancer, respectively. For uterine corpus cancer, updated survival data of the four trials (NRG-GY018, RUBY, AtTEnd, DUO-E) for endometrial cancer and the first survival data of LMS-04 trial for leiomyosarcoma were described. For ovarian cancer, the final overall survival results of PRIMA study were followed by DUO-O, ATHENA-combo, and FIRST-ENGOT-OV44 trial in different disease conditions. Finally, the results of DESTINY-PanTumor02, a basket trial of trastuzumab deruxtecan, were briefly addressed.-
dc.languageEnglish-
dc.publisherAsian Society of Gynecologic Oncology : Taehan Puin Chongyang Hakhoe-
dc.relation.isPartOfJOURNAL OF GYNECOLOGIC ONCOLOGY-
dc.relation.isPartOfJOURNAL OF GYNECOLOGIC ONCOLOGY-
dc.subject.MESHClinical Trials as Topic-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHOvarian Neoplasms* / therapy-
dc.subject.MESHUterine Cervical Neoplasms* / pathology-
dc.subject.MESHUterine Cervical Neoplasms* / therapy-
dc.subject.MESHUterine Neoplasms* / therapy-
dc.titleGynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers-
dc.typeArticle-
dc.contributor.googleauthorLee, Sung Jong-
dc.contributor.googleauthorYoo, Ji Geun-
dc.contributor.googleauthorKim, Jin Hwi-
dc.contributor.googleauthorPark, Jeong-Yeol-
dc.contributor.googleauthorLee, Jung-Yun-
dc.contributor.googleauthorLee, Yoo-Young-
dc.contributor.googleauthorSuh, Dong Hoon-
dc.identifier.doi10.3802/jgo.2025.36.e72-
dc.relation.journalcodeJ01428-
dc.identifier.eissn2005-0399-
dc.identifier.pmid39900347-
dc.subject.keywordGynecologic Neoplasms-
dc.subject.keywordImmunotherapy-
dc.subject.keywordMolecular Targeted Therapy-
dc.subject.keywordPoly(ADP-Ribose) Polymerase Inhibitor-
dc.subject.keywordImmunoconjugates-
dc.contributor.affiliatedAuthorLee, Jung-Yun-
dc.identifier.scopusid2-s2.0-85217070871-
dc.identifier.wosid001411526300005-
dc.citation.volume36-
dc.citation.number1-
dc.identifier.bibliographicCitationJOURNAL OF GYNECOLOGIC ONCOLOGY, Vol.36(1), 2025-01-
dc.identifier.rimsid87964-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorGynecologic Neoplasms-
dc.subject.keywordAuthorImmunotherapy-
dc.subject.keywordAuthorMolecular Targeted Therapy-
dc.subject.keywordAuthorPoly(ADP-Ribose) Polymerase Inhibitor-
dc.subject.keywordAuthorImmunoconjugates-
dc.subject.keywordPlusCHEMOTHERAPY-
dc.subject.keywordPlusWOMEN-
dc.type.docTypeArticle-
dc.identifier.kciidART003169679-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalWebOfScienceCategoryObstetrics & Gynecology-
dc.relation.journalResearchAreaOncology-
dc.relation.journalResearchAreaObstetrics & Gynecology-
dc.identifier.articlenoe72-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links